US Patent Issued to Pfizer on May 20 for "Compounds for the treatment of BRAF-associated diseases and disorders" (Colorado Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,509, issued on May 20, was assigned to Pfizer Inc. (New York).

"Compounds for the treatment of BRAF-associated diseases and disorders" was invented by Patrick Michael Doerner Barbour (Westminster, Colo.), Tanna Marie Bettendorf (Boulder, Colo.), Dean Russell Kahn (Longmont, Colo.), Alex Andrew Kellum (Boulder, Colo.), Ellen Ruth Laird (Longmont, Colo.), David Austin Moreno (Centennial, Colo.) and Li Ren (Superior, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is a compound of the Formula I:or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7 and L are as defined herein, for the treatment of BRAF-as...